Home » Newsletters » BioWorld

BioWorld

Oct. 13, 2000

View Archived Issues

Onyx Raises $45M In Follow-On Despite Current 'Difficult Market'

Icos Files For Public Offering Intended To Bring In $240M

Other News To Note

Senate Holds Off Until Next Week Reimportation Bill Vote

Elitra Adding Antifungal Program Through $19M Mycota Purchase

Introgen Prices $32M IPO, But Comes In Well Under Estimate

Yale Scientist Lays Bare Secret Cellular Manipulations Of Toxin Unleashed On Us By

J&J Stalls Trials Of Flu Drug; BioCryst Stock Bears Brunt